Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
New Data on Thymosin Beta 4 Reported at Third International Symposium on Thymosins in Health and Disease
The first day of the symposium included a keynote talk by Dr. Deepak Srivastava, Director of the Gladstone Institute of Cardiovascular Disease, on the reprogramming of cardiac cells by Tβ4.
The Grammy-winning drummer with iconic hippie rock group the Grateful Dead is teaming with Deepak Srivastava, the head of San Francisco's Gladstone Institute for Cardiovascular Research, in an effort to discover the sounds that cells make.
In a paper published last month in Neuron, investigators Anatol Kreitzer and Talia Lerner, at the Gladstone Institute of Neurological Disease in San Francisco showed that knocking out the RGS4 protein alleviated the aberrant motor control symptoms in dopamine-deficient mice used to model for Parkinson's disease.
Gladstone Institute of Cardiovascular Disease Senior Investigator Sheng Ding, PhD is cited as a coauthor of this important paper published in the journal Proceedings of the National Academy of Sciences.
More than a million people in the U.S. suffer from congenital heart disease, but now researchers at San Francisco's Gladstone Institutes believe a kind of genetic switch, flipped in the wrong position before birth, could be responsible for at least some of those cases.
Matthew Hirschey talks to Scientific American about his career and his experiences as a postdoctoral fellow at Gladstone.